Cargando…

Transplant-Associated Thrombotic Microangiopathy in the Context of Allogenic Hematopoietic Stem Cell Transplantation: Where We Stand

Transplant-associated thrombotic microangiopathy (TA-TMA) constitutes a significant contributor to the increased morbidity and mortality after allogenic hematopoietic stem cell transplantation (allo-HSCT). TA-TMA is a heterogenous disease, characterized by the triad of endothelial cell activation, c...

Descripción completa

Detalles Bibliográficos
Autor principal:	Lazana, Ioanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863862/ https://www.ncbi.nlm.nih.gov/pubmed/36674666 http://dx.doi.org/10.3390/ijms24021159

Ejemplares similares

Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go
por: Lv, Meng, et al.
Publicado: (2012)

A case of transplantation-associated thrombotic microangiopathy with autopsy-proven fatal myocardial ischemia after allogeneic hematopoietic stem cell transplantation
por: Sasaki, Ken, et al.
Publicado: (2020)

Variable clinical manifestations of hematopoietic stem cell transplant‐associated thrombotic microangiopathy
por: Jia, Chenguang, et al.
Publicado: (2019)

Renal and Neurological Response with Eculizumab in a Patient with Transplant Associated Thrombotic Microangiopathy after Allogeneic Hematopoietic Progenitor Cell Transplantation
por: Sevindik, Ömür Gökmen, et al.
Publicado: (2015)

Mechanisms of endothelial injury and transplant-associated thrombotic microangiopathy in tandem autologous hematopoietic stem cell transplant for neuroblastoma
por: Sabulski, Anthony, et al.
Publicado: (2023)

Hematopoietic stem cell transplantation-associated thrombotic microangiopathy and the role of advanced practice providers and pharmacists
por: Mahmoudjafari, Zahra, et al.
Publicado: (2023)

Endothelial Dysfunction Syndromes after Allogeneic Stem Cell Transplantation
por: Vythoulkas, Dionysios, et al.
Publicado: (2023)

Clinical characteristics of pediatric allogeneic hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA): a retrospective single-center analysis
por: Luo, Linlin, et al.
Publicado: (2023)

Thrombotic microangiopathy following haematopoietic stem cell transplant
por: Seaby, Eleanor G., et al.
Publicado: (2017)

Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy
por: Gavriilaki, Eleni, et al.
Publicado: (2021)

Complement System as a New Target for Hematopoietic Stem Cell Transplantation-Related Thrombotic Microangiopathy
por: Ardissino, Gianluigi, et al.
Publicado: (2022)

Hematopoietic cell transplantation-associated thrombotic microangiopathy: a review of pathophysiology, diagnosis, and treatment
por: Rosenthal, Joseph
Publicado: (2016)

2487. Vaccination Rates in Post-Transplant Hematopoietic Stem Cell Transplant (HSCT) Patients: Where Do We Stand?
por: Ahmad, Hiba, et al.
Publicado: (2018)

Narsoplimab for severe transplant-associated thrombotic microangiopathy
por: Pandrowala, Ambreen, et al.
Publicado: (2023)

Transplant-Associated Thrombotic Microangiopathy in Pediatric Hematopoietic Cell Transplant Recipients: A Practical Approach to Diagnosis and Management
por: Dvorak, Christopher C., et al.
Publicado: (2019)

Doxycycline for haematopoietic stem cell transplantation-related thrombotic microangiopathy
por: Izzedine, Hassane, et al.
Publicado: (2010)

Therapeutic Drug Monitoring of Conditioning Agents in Pediatric Allogeneic Stem Cell Transplantation; Where do We Stand?
por: van der Stoep, M. Y. Eileen C., et al.
Publicado: (2022)

Thrombotic Microangiopathy in Haematopoietic Cell Transplantation: an Update
por: Stavrou, Evi, et al.
Publicado: (2010)

Renal Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation: Involvement of Chronic Graft-Versus-Host Disease
por: Mii, Akiko, et al.
Publicado: (2018)

Cerebral vascular injury in transplant-associated thrombotic microangiopathy
por: Sabulski, Anthony, et al.
Publicado: (2022)

Characteristics and management of thrombotic microangiopathy in kidney transplantation
por: Cho, Wonyong, et al.
Publicado: (2023)

Editorial: Immune Profile After Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: Where Do We Stand?
por: Malmegrim, Kelen Cristina Ribeiro, et al.
Publicado: (2020)

Clofarabine in Pediatric Acute Relapsed or Refractory Leukemia: Where Do We Stand on the Bridge to Hematopoietic Stem Cell Transplantation?
por: Ramiz, Sarah, et al.
Publicado: (2023)

Thrombotic Microangiopathy Associated with Pazopanib in a Kidney Transplant Recipient
por: Kalla, Shabana, et al.
Publicado: (2021)

Use of Eculizumab in Pediatric Patients With Transplant Associated Thrombotic Microangiopathy
por: Gomez-Ganda, Laura, et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells in the Context of Allogeneic Hematopoietic Stem Cell Transplantation
por: D'Aveni, Maud, et al.
Publicado: (2020)

Allogeneic hematopoietic stem-cell transplantation for myelofibrosis
por: Zhang, Lining, et al.
Publicado: (2020)

von Willebrand Factor as a Predictor for Transplant-Associated Thrombotic Microangiopathy
por: Xu, Zhenzhen, et al.
Publicado: (2020)

Eculizumab Treatment in a Patient with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy and Steroid-Refractory Acute Graft Versus Host Disease
por: Fernández, Cristina, et al.
Publicado: (2015)

Serious Hemorrhagic Complications After Successful Treatment of Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy With Defibrotide in Pediatric Patient With Myelodysplastic Syndrome
por: Laberko, Alexandra, et al.
Publicado: (2020)

Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation–Associated Thrombotic Microangiopathy
por: Khaled, Samer K., et al.
Publicado: (2022)

Transplant-associated thrombotic microangiopathy: a rare but deadly complication post orthotopic heart transplantation
por: Ruiz-Morales, Jose, et al.
Publicado: (2022)

Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: Where do we stand? Volume II
por: Malmegrim, K. C. R., et al.
Publicado: (2022)

Post transplant thrombotic microangiopathy causing acute renal failure
por: Qutube, S., et al.
Publicado: (2009)

Thrombotic Microangiopathy in a Kidney Transplant Patient With COVID-19
por: Bascuñana, Arturo, et al.
Publicado: (2020)

Liver transplantation for hepatocellular carcinoma: Where do we stand?
por: Santopaolo, Francesco, et al.
Publicado: (2019)

Thrombotic Microangiopathy With Granulomatosis Interstitial Nephritis in an Allogenic Bone Marrow Transplant Patient: A Case Report and Review of the Literature
por: Mirza, Abu-Sayeef, et al.
Publicado: (2017)

New Allogeneic Hematopoietic Stem Cell Transplantation Method: Hematopoietic Stem Cell Transplantation Plus Thymus Transplantation for Intractable Diseases
por: Hosaka, Naoki
Publicado: (2013)

Allogeneic hematopoietic stem cell transplantation in mycosis fungoides
por: Atalla, Angelo, et al.
Publicado: (2013)

Epigenetic therapy in allogeneic hematopoietic stem cell transplantation
por: Bashir, Qaiser, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_cqfs9ckar6krdv2s7ojfir1sva